Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
AM Menzies, DB Johnson, S Ramanujam, VG Atkinson, ANM Wong, JJ Park, JL McQuade, AN Shoushtari, KK Tsai, Z Eroglu, O Klein, JC Hassel, JA Sosman, A Guminski, RJ Sullivan, A Ribas, MS Carlino, MA Davies, SK Sandhu, GV Long
Annals of Oncology | OXFORD UNIV PRESS | Published : 2017
AMM had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The authors wish to acknowledge the assistance of Anna Hoadley RN, Georgia Cairns RN, Elizabeth Liniker MD and Maria Czupryn RN. AMM is supported by a Cancer Institute NSW fellowship.